Search Page

1

Cite

Share

Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment.

Chow EJ, Leger KJ, Bhatt NS, Mulrooney DA, Ross CJ, Aggarwal S, Bansal N, Ehrhardt MJ, Armenian SH, Scott JM, Hong B. Chow EJ, et al. Among authors: ross cj. Cardiovasc Res. 2019 Apr 15;115(5):922-934. doi: 10.1093/cvr/cvz031. Cardiovasc Res. 2019. PMID: 30768157 Free PMC article. Review.

Cite

Share

2

Cite

Share

RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy.

Magdy T, Jiang Z, Jouni M, Fonoudi H, Lyra-Leite D, Jung G, Romero-Tejeda M, Kuo HH, Fetterman KA, Gharib M, Burmeister BT, Zhao M, Sapkota Y, Ross CJ, Carleton BC, Bernstein D, Burridge PW. Magdy T, et al. Among authors: ross cj. Cell Stem Cell. 2021 Dec 2;28(12):2076-2089.e7. doi: 10.1016/j.stem.2021.08.006. Epub 2021 Sep 15. Cell Stem Cell. 2021. PMID: 34525346

Cite

Share

3

Cite

Share

Promoting neuroplasticity for motor rehabilitation after stroke: considering the effects of aerobic exercise and genetic variation on brain-derived neurotrophic factor.

Mang CS, Campbell KL, Ross CJ, Boyd LA. Mang CS, et al. Among authors: ross cj. Phys Ther. 2013 Dec;93(12):1707-16. doi: 10.2522/ptj.20130053. Epub 2013 Aug 1. Phys Ther. 2013. PMID: 23907078 Free PMC article. Review.

Cite

Share

4

Cite

Share

Les tests pharmacogénomiques: Améliorer le recours personnalisé aux médicaments pour les patients.

Loucks CM, Groeneweg G, Roy C, Lee DK, Rieder MJ, Lebel D, Ito S, Ross CJ, Carleton BC. Loucks CM, et al. Among authors: ross cj. Can Fam Physician. 2020 Apr;66(4):247-249. Can Fam Physician. 2020. PMID: 32273408 Free PMC article. French. No abstract available.

Cite

Share

5

Cite

Share

Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity.

Magdy T, Jouni M, Kuo HH, Weddle CJ, Lyra-Leite D, Fonoudi H, Romero-Tejeda M, Gharib M, Javed H, Fajardo G, Ross CJD, Carleton BC, Bernstein D, Burridge PW. Magdy T, et al. Among authors: ross cjd. Circulation. 2022 Jan 25;145(4):279-294. doi: 10.1161/CIRCULATIONAHA.121.055801. Epub 2021 Dec 7. Circulation. 2022. PMID: 34874743

Cite

Share

6

Cite

Share

Reducing anthracycline-induced cardiotoxicity through pharmacogenetics.

Scott E, Hasbullah JS, Ross CJ, Carleton BC. Scott E, et al. Among authors: ross cj. Pharmacogenomics. 2018 Oct;19(15):1147-1150. doi: 10.2217/pgs-2018-0124. Epub 2018 Sep 14. Pharmacogenomics. 2018. PMID: 30213233 Free article. No abstract available.

Cite

Share

7

Cite

Share

Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.

Chang WC, Tanoshima R, Ross CJD, Carleton BC. Chang WC, et al. Among authors: ross cjd. Annu Rev Pharmacol Toxicol. 2021 Jan 6;61:65-84. doi: 10.1146/annurev-pharmtox-030920-025745. Epub 2020 Oct 2. Annu Rev Pharmacol Toxicol. 2021. PMID: 33006916 Review.

Cite

Share

8

Cite

Share

Prevention of adverse drug effects: a pharmacogenomic approach.

Scott EN, Hasbullah JS, Carleton BC, Ross CJD. Scott EN, et al. Among authors: ross cjd. Curr Opin Pediatr. 2020 Oct;32(5):646-653. doi: 10.1097/MOP.0000000000000935. Curr Opin Pediatr. 2020. PMID: 32796162 Review.

Cite

Share

9

Cite

Share

Vincristine-induced peripheral neurotoxicity: A prospective cohort.

Nama N, Barker MK, Kwan C, Sabarre C, Solimano V, Rankin A, Raabe J, Ross CJ, Carleton B, Zwicker JG, Rassekh SR. Nama N, et al. Among authors: ross cj. Pediatr Hematol Oncol. 2020 Feb;37(1):15-28. doi: 10.1080/08880018.2019.1677832. Epub 2019 Nov 4. Pediatr Hematol Oncol. 2020. PMID: 31682156

Cite

Share

10

Cite

Share

Uncovering deeply conserved motif combinations in rapidly evolving noncoding sequences.

Ross CJ, Rom A, Spinrad A, Gelbard-Solodkin D, Degani N, Ulitsky I. Ross CJ, et al. Genome Biol. 2021 Jan 11;22(1):29. doi: 10.1186/s13059-020-02247-1. Genome Biol. 2021. PMID: 33430943 Free PMC article.

Cite

Share